Malignant fibrous histiocytoma (MFH) is a rare tumor of the heart and the patients with these tumors usually have a poor prognosis. We report a case of MFH with an origin from the left superior pulmonary vein, involving the left atrium and protruding through the mitral valve, which needed urgent surgery. Complete resection was performed but local recurrence was detected one month later.
References
[1]
R. Virmani, A. Burke and A. Farb, “Atlas of Cardio-Vas-Cular Pathology,” Saunders, Philadelphia, 1996.
[2]
A. Al-Mamgani, L. Baartman, M. Baaijens, et al., “Cardiac Metastases,” International Journal of Clinical Oncology, Vol. 13, No. 4, 2008, pp. 369-372.
doi:10.1007/s10147-007-0749-8
[3]
H. A. McAllister and J. J. Fenoglio Jr., “Tumors of the Cardiovascular System,” Atlas of Tumor Pathology, Series 2, Armed Forces Institute of Pathology, Washington, 1978.
[4]
L. Shapiro, “Cardiac Tumors: Diagnosis and Management,” Heart, Vol. 85, No. 2, 2001, pp. 218-222.
doi:10.1136/heart.85.2.218
[5]
M. M. Kearney, E. H. Soule and J. C. Ivins, “Malignant Fibrous Histiocytoma a Retrospective Study of 167 Cases,” Cancer, Vol. 45, No. 1, 2006, pp. 167-178.
doi:10.1002/1097-0142(19800101)45:1<167::AID-CNCR2820450127>3.0.CO;2-8
[6]
O. M. Al-Agha and A. A. Igbokwe, “Malignant Fibrous Histiocytoma: Between the Past and the Present,” Archives of Pathology & Laboratory Medicine, Vol. 132, No. 6, 2008, pp. 1030-1035.
[7]
L. H. Cohn, “Cardiac Surgery in the Adult,” Third Edition, McGraw-Hill, Toronto, 2008.
[8]
S. W. Weiss and. F. M. Enzinger, “Myxoid Variant of Malignant Fibrous Histiocytoma,” Cancer, Vol. 39, No. 4, 1977, pp. 1672-1685.
doi:10.1002/1097-0142(197704)39:4<1672::AID-CNCR2820390442>3.0.CO;2-C
